Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus reuteri for radiotherapy-induced oral mucositis
NCT03552458Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jun 2018
- Primary completion
- Dec 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lactobacillus reuteri in oral mucositis (OM) (2 arms), sponsored by National University Hospital. Primary endpoints: Oral Mucositis Severity Assessment, Duration of Oral Mucositis and 2 more. Status: unknown.
02
Drugs
lactobacillus reuteri
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03552458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03552458.